Your browser doesn't support javascript.
loading
Familial Recurrence Patterns in Congenitally Corrected Transposition of the Great Arteries: An International Study.
Tortigue, Marine; Nield, Lynne E; Karakachoff, Matilde; McLeod, Christopher J; Belli, Emre; Babu-Narayan, Sonya V; Prigent, Solène; Boet, Angèle; Conway, Miriam; Elder, Robert W; Ladouceur, Magalie; Khairy, Paul; Kowalik, Ewa; Kalfa, David M; Barron, David J; Mussa, Shafi; Hiippala, Anita; Temple, Joel; Abadir, Sylvia; Le Gloan, Laurianne; Lachaud, Matthias; Sanatani, Shubhayan; Thambo, Jean-Benoit; Gronier, Céline Grunenwald; Amedro, Pascal; Vaksmann, Guy; Charbonneau, Anne; Koutbi, Linda; Ovaert, Caroline; Houeijeh, Ali; Combes, Nicolas; Maury, Philippe; Duthoit, Guillaume; Hiel, Bérengère; Erickson, Christopher C; Bonnet, Caroline; Van Hare, George F; Dina, Christian; Karsenty, Clément; Fournier, Emmanuelle; Le Bloa, Mathieu; Pass, Robert H; Liberman, Leonardo; Happonen, Juha-Matti; Perry, James C; Romefort, Bénédicte; Benbrik, Nadir; Hauet, Quentin; Fraisse, Alain; Gatzoulis, Michael A.
Afiliación
  • Tortigue M; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (M.T., L.L.G., C.D., R.R., J.-J.S., A.-E.B.).
  • Nield LE; Nantes Université, CHU Nantes, Department of Pediatric Cardiology and Pediatric Cardiac Surgery, France (M.T., S.P., C.G.G., B.R., N.B., Q.H., A.-E.B.).
  • Karakachoff M; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, France (M.T., S.P., C.G.G., A.-E.B.).
  • McLeod CJ; Division of Pediatric Cardiology, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Canada (L.E.N., D.J.B.).
  • Belli E; Clinique des Données, CHU Nantes, INSERM, CIC 1413, France (M.K.).
  • Babu-Narayan SV; Department of Cardiovascular Diseases, Mayo Clinic, Rochester, MN (C.J.M.).
  • Prigent S; Department of Pediatric and Adult Congenital Heart Disase, M3C Marie Lannelongue Hospital, Groupe Hospitalier Saint Joseph, Paris, France (E.B., A.B., N.C., E.F.).
  • Boet A; National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, United Kingdom (S.V.B.-N., M.C., A.F., M.A.G., S.Y.H.).
  • Conway M; Nantes Université, CHU Nantes, Department of Pediatric Cardiology and Pediatric Cardiac Surgery, France (M.T., S.P., C.G.G., B.R., N.B., Q.H., A.-E.B.).
  • Elder RW; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, France (M.T., S.P., C.G.G., A.-E.B.).
  • Ladouceur M; Department of Pediatric and Adult Congenital Heart Disase, M3C Marie Lannelongue Hospital, Groupe Hospitalier Saint Joseph, Paris, France (E.B., A.B., N.C., E.F.).
  • Khairy P; National Heart and Lung Institute, Imperial College London, Royal Brompton and Harefield Hospitals, United Kingdom (S.V.B.-N., M.C., A.F., M.A.G., S.Y.H.).
  • Kowalik E; Department of Pediatrics, Yale University School of Medicine, New Haven, CT (R.W.E.).
  • Kalfa DM; Department of Adult Congenital Heart Diseases, M3C Hôpital Européen Georges Pompidou, Paris, France (M.L.).
  • Barron DJ; Electrophysiology Service and Adult Congenital Heart Center, Montreal Heart Institute, University of Montreal, Quebec, Canada (P.K., S.A.).
  • Mussa S; Department of Congenital Heart Diseases, National Institute of Cardiology, Warsaw, Poland (E.K.).
  • Hiippala A; Department of Pediatric and Congenital Cardiac Surgery, Morgan Stanley Children's Hospital - New York Presbyterian, Columbia University Medical Center, NY (D.M.K., L.L., E.A.B.).
  • Temple J; Division of Pediatric Cardiology, Labatt Family Heart Centre, The Hospital for Sick Children, University of Toronto, Canada (L.E.N., D.J.B.).
  • Abadir S; Department of Congenital Cardiac Surgery, University Hospitals Bristol NHS Foundation Trust, United Kingdom (S.M.).
  • Le Gloan L; Department of Pediatric Cardiology, New Children's Hospital, Helsinki University Hospital, Finland (A.H., J.-M.H.).
  • Lachaud M; Department of Pediatrics, Nemours Cardiac Center, Alfred I. duPont Hospital for Children, Wilmington, DE (J.T.).
  • Sanatani S; Electrophysiology Service and Adult Congenital Heart Center, Montreal Heart Institute, University of Montreal, Quebec, Canada (P.K., S.A.).
  • Thambo JB; Division of Cardiology, CHU Mère-Enfant Sainte-Justine, University of Montreal, Quebec, Canada (S.A.).
  • Gronier CG; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (M.T., L.L.G., C.D., R.R., J.-J.S., A.-E.B.).
  • Amedro P; Department of Cardiology, CHU Nantes, Nantes, France (L.L.G.).
  • Vaksmann G; Department of Pediatric Cardiology, CHU Grenoble, France (M.L.).
  • Charbonneau A; Division of Cardiology, British Columbia Children's Hospital, University of British Columbia, Vancouver, Canada (S.S.).
  • Koutbi L; Department of Cardiology, CHU Bordeaux, France (J.-B.T., P.A.).
  • Ovaert C; Nantes Université, CHU Nantes, Department of Pediatric Cardiology and Pediatric Cardiac Surgery, France (M.T., S.P., C.G.G., B.R., N.B., Q.H., A.-E.B.).
  • Houeijeh A; Nantes Université, CHU Nantes, INSERM, CIC FEA 1413, France (M.T., S.P., C.G.G., A.-E.B.).
  • Combes N; Department of Cardiology, CHU Bordeaux, France (J.-B.T., P.A.).
  • Maury P; PhyMedExp, CNRS, INSERM, University of Montpellier, France (P.A.).
  • Duthoit G; Department of Pediatric Cardiology, Hôpital Privé de La Louvière, Lille, France (G.V.).
  • Hiel B; Department of Pediatric and Congenital Cardiology, American Memorial Hospital, CHU Reims, France (A.C.).
  • Erickson CC; Department of Cardiology (L.K.), La Timone Hospital, CHU Marseille, France.
  • Bonnet C; Department of Pediatric Cardiology (C.O.), La Timone Hospital, CHU Marseille, France.
  • Van Hare GF; Marseille Medical Genetics, Inserm UMR 1251, Aix-Marseille University, France (C.O.).
  • Dina C; Department of Pediatric Cardiology, CHRU Lille, France (A.H.).
  • Karsenty C; Department of Pediatric and Adult Congenital Heart Disase, M3C Marie Lannelongue Hospital, Groupe Hospitalier Saint Joseph, Paris, France (E.B., A.B., N.C., E.F.).
  • Fournier E; Department of Cardiology, Pasteur Clinic, Toulouse, France (N.C.).
  • Le Bloa M; Department of Cardiology (P.M.), CHU Toulouse, France.
  • Pass RH; Department of Cardiology, Groupe Hospitalier Pitié Salpétrière, Sorbonne Université, Paris, France (G.D.).
  • Liberman L; Department of Pediatric Cardiology, CHU Amiens, France (B.H.).
  • Happonen JM; UDivision of Pediatric Cardiology, University of Nebraska Medical Center, Children's Hospital and Medical Center, Omaha, NE (C.C.E.).
  • Perry JC; Department of Pediatric Cardiology, CHU Lyon, France (C.B.).
  • Romefort B; Division of Pediatric Cardiology, St Louis Children's Hospital, Washington University School of Medicine (G.F.V.H.).
  • Benbrik N; Nantes Université, CHU Nantes, CNRS, INSERM, l'institut du thorax, France (M.T., L.L.G., C.D., R.R., J.-J.S., A.-E.B.).
  • Hauet Q; Department of Pediatric and Congenital Cardiology, Children's Hospital (C.K.), CHU Toulouse, France.
  • Fraisse A; Institut des Maladies Métaboliques et Cardiovasculaires, Inserm UMR 1048, Université de Toulouse, France (C.K.).
  • Gatzoulis MA; Department of Pediatric and Adult Congenital Heart Disase, M3C Marie Lannelongue Hospital, Groupe Hospitalier Saint Joseph, Paris, France (E.B., A.B., N.C., E.F.).
Circ Genom Precis Med ; 15(3): e003464, 2022 06.
Article en En | MEDLINE | ID: mdl-35549293
ABSTRACT

BACKGROUND:

Congenitally corrected transposition of the great arteries (ccTGA) is a rare disease of unknown cause. We aimed to better understand familial recurrence patterns.

METHODS:

An international, multicentre, retrospective cohort study was conducted in 29 tertiary hospitals in 6 countries between 1990 and 2018, entailing investigation of 1043 unrelated ccTGA probands.

RESULTS:

Laterality defects and atrioventricular block at diagnosis were observed in 29.9% and 9.3%, respectively. ccTGA was associated with primary ciliary dyskinesia in 11 patients. Parental consanguinity was noted in 3.4% cases. A congenital heart defect was diagnosed in 81 relatives from 69 families, 58% of them being first-degree relatives, including 28 siblings. The most prevalent defects in relatives were dextro-transposition of the great arteries (28.4%), laterality defects (13.6%), and ccTGA (11.1%); 36 new familial clusters were described, including 8 pedigrees with concordant familial aggregation of ccTGA, 19 pedigrees with familial co-segregation of ccTGA and dextro-transposition of the great arteries, and 9 familial co-segregation of ccTGA and laterality defects. In one family co-segregation of ccTGA, dextro-transposition of the great arteries and heterotaxy syndrome in 3 distinct relatives was found. In another family, twins both displayed ccTGA and primary ciliary dyskinesia.

CONCLUSIONS:

ccTGA is not always a sporadic congenital heart defect. Familial clusters as well as evidence of an association between ccTGA, dextro-transposition of the great arteries, laterality defects and in some cases primary ciliary dyskinesia, strongly suggest a common pathogenetic pathway involving laterality genes in the pathophysiology of ccTGA.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transposición de los Grandes Vasos / Trastornos de la Motilidad Ciliar / Cardiopatías Congénitas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circ Genom Precis Med Año: 2022 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Transposición de los Grandes Vasos / Trastornos de la Motilidad Ciliar / Cardiopatías Congénitas Tipo de estudio: Diagnostic_studies / Observational_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Circ Genom Precis Med Año: 2022 Tipo del documento: Article